Redefining the Multiple Sclerosis Severity Score (MSSS): The effect of sex and onset phenotype

Background: The Multiple Sclerosis Severity Score (MSSS) is a widely used measure of the disability progression rate. However, the global MSSS may not be the best basis for comparison between all patient groups. Objective: We evaluated sex-specific and onset phenotype–specific MSSS matrices to deter...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Multiple sclerosis 2020-11, Vol.26 (13), p.1765-1774, Article 1352458519881994
Hauptverfasser: Zhou, Yuan, Claflin, Suzi B, Stankovich, Jim, van der Mei, Ingrid, Simpson, Steve, Roxburgh, Richard H, Kalincik, Tomas, Blizzard, Leigh, Lugaresi, Alessandra, Alroughani, Raed, Sajedi, Seyed Aidin, Butzkueven, Helmut, Pucci, Eugenio, Spitaleri, Daniele LA, Granella, Franco, Cristiano, Edgardo, Yamout, Bassem, Hughes, Stella, Gouider, Riadh, Sánchez Menoyo, José Luis, Olascoaga, Javier, McGuigan, Chris, Shaw, Cameron, Kermode, Allan G, Kasa, Krisztian, Al-Harbi, Talal, Altintas, Ayse, Laureys, Guy, Fragoso, Yara, Hardy, Todd A, Csepany, Tunde, Sirbu, Carmen-Adella, Decoo, Danny, Sas, Attila, Alvarez-Cermeño, Jose C, Kotkata, Karim, Millán-Pascual, Jorge, Taylor, Bruce V
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background: The Multiple Sclerosis Severity Score (MSSS) is a widely used measure of the disability progression rate. However, the global MSSS may not be the best basis for comparison between all patient groups. Objective: We evaluated sex-specific and onset phenotype–specific MSSS matrices to determine if they were more effective than the global MSSS as a basis for comparison within these subsets. Methods: Using a large international dataset of multiple sclerosis (MS) patient records and the original MSSS algorithm, we constructed global, sex-specific and onset phenotype–specific MSSS matrices. We compared matrices using permutation analysis. Results: Our final dataset included 30,203 MS cases, with 28.9% males and 6.5% progressive-onset cases. Our global MSSS matrix did not differ from previously published data (p > 0.05). The progressive-onset-specific matrix differed significantly from the relapsing-onset-specific matrix (p 
ISSN:1352-4585
1477-0970
DOI:10.1177/1352458519881994